Drug Shortage Report for VIVAXIM
Report ID | 1300 |
Drug Identification Number | 02248361 |
Brand name | VIVAXIM |
Common or Proper name | Combined purified Vi polysaccharide typhoid and inactivated hepatitis A vaccine |
Company Name | SANOFI PASTEUR LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE HEPATITIS A VACCINE, INACTIVATED |
Strength(s) | 25MCG 160UNIT |
Dosage form(s) | SOLUTION SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1 x 1.0 mL (single dose) dual chamber syringe / 1 seringue (dose unique) à double compartiment de 1,0 mL |
ATC code | J07CA |
ATC description | BACTERIAL AND VIRAL VACCINES, COMBINED |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2016-11-16 |
Actual start date | 2016-11-16 |
Estimated end date | 2019-01-31 |
Actual end date | 2019-09-05 |
Shortage status | Resolved |
Updated date | 2019-09-06 |
Company comments | The shortage has been resolved. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-13 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v3 | 2017-03-13 | English | Compare |
v4 | 2017-03-13 | English | Compare |
v5 | 2017-03-13 | English | Compare |
v6 | 2017-03-13 | French | Compare |
v7 | 2017-04-11 | English | Compare |
v8 | 2017-04-11 | French | Compare |
v9 | 2017-08-03 | English | Compare |
v10 | 2017-08-03 | French | Compare |
v11 | 2019-09-05 | English | Compare |
v12 | 2019-09-05 | French | Compare |
v13 | 2019-09-06 | English | Compare |
Showing 1 to 13 of 13